Clinical trials in Côte D'Ivoire
114 studies list at least one site in Côte D'Ivoire. 24 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-11-04.
Get an email when these change. Save the studies in Côte D'Ivoire recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Most studied here
Who runs them
ANRS, Emerging Infectious Diseases (21) · Novartis Pharmaceuticals (8) · Swiss Tropical & Public Health Institute (6) · French Africa Pediatric Oncology Group (5) · Institut de Recherche pour le Developpement (5) · French National Agency for Research on AIDS and Viral Hepatitis (4) · London School of Hygiene and Tropical Medicine (4) · Institut National de la Santé Et de la Recherche Médicale, France (3)
What changed recently
From the registry's own updates since Oct 13, 2026.
Results posted1
Studies
Recruiting first, then most recently updated. Showing 50 of 114 — search for more.
- A Phase III Trial to Evaluate the Safety and Efficacy of Anti-inflammatory Drugs in Addition to Praziquantel in Girls and Women With Female Genital SchistosomiasisNot yet recruitingNCT07915518Phase 3
- Efficacy and Safety Study of Dovramilast in People With Leprosy Type 2 ReactionRecruitingNCT07172659Phase 2
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2)RecruitingNCT07811908Phase 2
- Integrating Point of Care Testing (POCT) For Newborn Screening and Early Care for Sickle Cell Disease in Yopougon, Côte d'IvoireRecruitingNCT07488520Phase 4
- Taabo Tutoring StudyRecruitingNCT07486778Not applicable
- Frailty, Geriatric Syndromes and Care Pathways of Older Adults Living With HIV in West AfricaRecruitingNCT07355413
- Improving Maternal and Neonatal Care-seeking Through a Video-informed Training Session During the Third Trimester of PregnancyNot yet recruitingNCT07819201Not applicable
- iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic DiseasesRecruitingNCT03549754
- An International Observational Study of Adults With Acute InfectionRecruitingNCT07069400
- DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 InfectionRecruitingNCT06203132Phase 3
- Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous MeningitisRecruitingNCT04145258Phase 3
- Improved Child Nutrition and Development Through Social TransfersNot yet recruitingNCT07569172Not applicable
- Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOPRecruitingNCT04794296
- Therapeutic Recommendations For The Treatment Of Children With A RetinoblastomaRecruitingNCT04425434
- Recommendations for the Treatment of Children With Burkitt's LymphomaRecruitingNCT04425421
- Therapeutic Recommendations for NephroblastomaRecruitingNCT04423484
- Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)RecruitingNCT07170748
- Improving Uptake of Antenatal Care Services in Rural Côte d'IvoireRecruitingNCT07341581Not applicable
- Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking AfricaRecruitingNCT03803735
- Introduction of Arpraziquantel Treatment for Schistosomiasis Control in Preschool-aged Children in Endemic Areas: A Small-scale Public Health Intervention StudyRecruitingNCT06698510
- Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)RecruitingNCT05580666Phase 3
- An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria VaccineRecruitingNCT07009847
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum MalariaRecruitingNCT05750628Phase 2
- Integrated HPV Vaccination and Adolescent Health in Ivory CoastRecruitingNCT06997705Not applicable
- Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum MalariaCompletedNCT05842954Phase 3
- Improving HPV Vaccination Coverage Among Adolescent Girls in Mali and Côte d'Ivoire Through Community Health Worker Follow-upCompletedNCT07807202Not applicable
- Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)CompletedNCT05312918
- Variants of SARS-CoV-2 Causing COVID-19 in AfricaCompletedNCT05311891
- ANRS 12372 MODERATO StudyCompletedNCT04022967Phase 3
- Digital Toolkit for Skin Diseases in LMICs: Part 2CompletedNCT06292260Not applicable
- Impact of an Innovative Childhood TB Diagnostic Approach Decentralized to District Hospital and Primary Health Care Levels on Childhood Tuberculosis Case Detection and Management in High Tuberculosis Incidence Countries (TB-Speed Decentralisation)CompletedNCT04038632Not applicable
- Validation of a Tuberculosis Treatment Decision Algorithm in HIV-infected Children (TB-Speed HIV)CompletedNCT04121026Not applicable
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B1)CompletedNCT07811882Phase 2
- Perennial Malaria Chemoprevention (PMC) in Côte d'IvoireCompletedNCT05856357
- Evaluation of "C'Est La Vie!" Digital Health EducationCompletedNCT07636629Not applicable
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B2)CompletedNCT07235033Phase 2
- Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum MalariaCompletedNCT04546633Phase 2
- Access to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP)CompletedNCT03459157Not applicable
- Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan AfricaCompletedNCT02626286Not applicable
- To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum MalariaCompletedNCT04675931Phase 2
- Net Transition Initiative: Efficacy of Two Next-generation Nets for Control of Malaria in Cote d'IvoireActive, not recruitingNCT05796193Not applicable
- Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant AlbendazoleCompletedNCT04311671Phase 3
- A Study to Collect Data to Build Artificial Intelligence Derived Algorithms for Estimating Risk of Iron Deficiency and Anaemia in African ChildrenCompletedNCT07186205
- Moxidectin for LF, Cote d'Ivoire (DOLF)CompletedNCT04410406Phase 3
- A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152)Active, not recruitingNCT05904886Phase 3
- Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia)CompletedNCT03831906Not applicable
- HIV-1 Subtype-specific Drug Resistance in Patients Failing Dolutegravir (DTG) Based RegimenCompletedNCT06285110
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum MalariaCompletedNCT07235020Phase 2
- Implementation and Effectiveness of Physical Activity to Prevent Disability in HIV-infected Adults Older Than 50 From Côte d'IvoireActive, not recruitingNCT06139497Not applicable
- Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe PneumoniaCompletedNCT03915366Phase 2/3